Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: GENB) | Delayed: 13.08 +0.18 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.90 | 52 Week High | $ | |||
| Open | $13.04 | 52 Week Low | $ | |||
| Day High | $13.18 | P/E | N/A | |||
| Day Low | $12.80 | EPS | $ | |||
| Volume | 98,126 | |||||
| (NASDAQ: GENB) | Delayed: 13.08 +0.18 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.90 | 52 Week High | $ | |||
| Open | $13.04 | 52 Week Low | $ | |||
| Day High | $13.18 | P/E | N/A | |||
| Day Low | $12.80 | EPS | $ | |||
| Volume | 98,126 | |||||
